Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. - Wikidata - awgldk - TriplyDB

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

http://www.wikidata.org/entity/Q37216929

about

From bowel to kidneys: the role of cubilin in physiology and disease Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure Megalin dependent urinary cystatin C excretion in ischemic kidney injury in rats.Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy.Renal lipid metabolism and lipotoxicity.Cellular cholesterol transport proteins in diabetic nephropathy.High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease Yishen Jiangzhuo Granules affect tubulointerstitial fibrosis via a mitochondrion-mediated apoptotic pathway.Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.Renal interstitial fibrosis: mechanisms and evaluation.Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.Heat shock pretreatment improves stem cell repair following ischemia-reperfusion injury via autophagy.Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female rats Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.Atherosclerosis in chronic kidney disease: the role of macrophages Statins in the management of dyslipidemia associated with chronic kidney disease.Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.Role of dyslipidemia in patients with chronic kidney disease.Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.HDL abnormalities in nephrotic syndrome and chronic kidney disease.Alterations of specific lipid groups in serum of obese humans: a review.The role of renin angiotensin system inhibition in kidney repair.Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation.Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease.Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD.Renal fibrosis: Primacy of the proximal tubule.Cross-talk between AMP-activated protein kinase and renin-angiotensin system in uninephrectomised rats.SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.Inflammatory stress reduces the effectiveness of statins in the kidney by disrupting HMGCoA reductase feedback regulation.Kidney disease models: tools to identify mechanisms and potential therapeutic targets.Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.

P2860

Q26852811-128CCF3F-43B4-42C2-A329-4467B6C14A1D Q28566456-A229846C-0ECB-43C1-A9B2-8D582EFEF4B5 Q33757885-C9BF688E-F4C0-4AEE-B2B3-A0174EB3D9B5 Q34308238-A6BFED00-64CF-48AD-9660-E252B9E849E3 Q34795819-BFC7CC07-1B5E-4DD8-AED2-5665E128E56D Q34825296-75790DB1-279C-484B-B58F-77A87936971C Q35236869-5045E840-2400-4B0D-982D-72206E6DF1B8 Q35500573-974CD9E7-3BF2-4D8B-9141-3FF7D6D30033 Q35500577-5F44DA66-4767-44C6-8DDB-AE380A5F6F61 Q35601604-C2BDF212-F08B-4178-8E9F-7732544BA182 Q35625838-C9BEBDB7-841E-44DE-AF6E-7A663F1C50E4 Q35747579-20A75F07-335E-42F1-9609-E10FFCF944DB Q35967489-D8B78B03-33C7-4D04-B5F3-CEBB306B4C63 Q36280389-5556E3ED-D463-432B-9751-1FED6689EE20 Q36350224-E8D8EA94-FFD1-416E-80CE-9B69743D47A8 Q36581341-38DB201B-B444-4B43-82AF-A994D1DE3698 Q36721867-D18E166D-4E44-4B7A-8690-F8CC0392DE56 Q36788430-C52AE90B-03B9-441B-A10D-0B595AB357A3 Q37603244-6023E805-AEFE-4D6F-8CAD-CFF9C31C2140 Q37640920-503F8913-B63B-482C-A1CF-7E466CF868B2 Q37811885-71327A80-2496-414C-B672-F1340428FFF3 Q37986355-C03F1CAD-3E56-4E2B-B05D-778A7B59B69B Q38076217-50C4246B-1D76-4645-A2B1-97D2FD660C37 Q38120646-6F8F39BC-857F-47E9-8796-4216B8482F99 Q38131300-3F00F229-BE1B-4B14-8E98-288087298F2C Q38633497-94F12E44-A2F3-48A6-A07B-9A645DBDE39A Q39023727-37AD7451-FB3F-4552-B5F7-9FB9175D4C3C Q41206891-DD80CEB5-5B10-4AD3-8013-76138E4429F5 Q41980428-132A01D5-9DAB-4367-BE0A-07DBB131BDB9 Q43199666-040B9B44-D66F-404D-9F6B-AF33330C9722 Q43247391-1DFB2629-CE64-4F46-99C6-5BA1BD6A55E6 Q44752587-89C635D2-B379-4A3E-9E2C-2645257355CC Q45986959-68BA0E5A-1002-4552-B0CA-95DB93D67B0C Q50095901-7279E7F7-13F8-498C-A820-320AD6BD2792 Q50097164-63496530-8B8F-4170-BD0E-035132EA8B2D Q51353323-FCAC48BD-7A37-46AD-9AE1-807FA40A54F2 Q51658757-F05A07A1-ABC3-4577-92C5-EDE737005EF0 Q52650772-C6B00A12-B810-43A1-973D-101B46E37E6A Q52668596-97987855-DCA1-4473-8AD2-C5141E15A83D Q53155161-A31C1CDF-FD2F-4CC8-B84E-781111719AFB

P2860

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

http://www.wikidata.org/entity/Q37216929

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Renal mass reduction results i ...... roteins in the remnant kidney.

@en

Renal mass reduction results i ...... roteins in the remnant kidney.

@nl

type

label

Renal mass reduction results i ...... roteins in the remnant kidney.

@en

Renal mass reduction results i ...... roteins in the remnant kidney.

@nl

prefLabel

Renal mass reduction results i ...... roteins in the remnant kidney.

@en

Renal mass reduction results i ...... roteins in the remnant kidney.

@nl

P1433

Q37216929-AA563F67-B905-400F-8385-7943FB2E6F73

P1476

Q37216929-189FC1E2-AC35-4442-9420-CAC94F156B84

P2093

Q37216929-0FA31F88-0250-457E-A903-ACF7B9324E94

Q37216929-4DA134A4-4DFC-4451-9CEB-E0D3325AAF1C

Q37216929-4F999E4F-243B-4F36-9424-DEC4705A0E99

Q37216929-B2EBC560-0704-4160-BF77-A9CD56FD4452

Q37216929-CF1E982E-8AFF-4AAA-BD85-174D61C302F6

P2860

Q37216929-01B68C22-2A04-4480-932A-C4D3CDBC1613

Q37216929-021522F0-1145-4BE7-985B-AC3F1C1799E8

Q37216929-02C7B6A0-C23A-403F-8506-9D17797F8521

Q37216929-02D1EB72-4223-4CF5-9071-B005F2BAE116

Q37216929-03E09005-29B0-4F18-85BE-19E062DD022D

Q37216929-042C00B9-18B1-47BB-BBEA-246396AA1AD0

Q37216929-05380AFA-0CEB-47C3-BE5B-72502373A857

Q37216929-071ED6FC-6E89-4365-BD46-4C0816E86805

Q37216929-077A0386-1F3B-4965-827D-A99045ADEB02

Q37216929-079AAD57-1F39-4766-81AD-BCB20B5589D4

P304

Q37216929-C6596459-05B2-4552-8506-38BA201FF6FF

P31

Q37216929-7AE041E7-2F7F-4231-A116-F0E7C725A250

P356

Q37216929-32C96D42-A6D6-4247-99BB-2D5295307A48

P433

Q37216929-787924B5-40B2-439B-8FD9-70CAB9F059D7

P478

Q37216929-0B70A270-C553-46FB-ACC2-4CED32274A8C

P577

Q37216929-F52F9B03-9A0E-4D89-8777-5D482AA13728

P698

Q37216929-50EA4803-0F16-45B8-BCC7-E3AC03F60076

P932

Q37216929-B0549030-C972-434C-8C40-4DBDC7CDDE0A

P356

AJPRENAL.90761.2008

P1433

American Journal of Physiology - Renal Physiology

P1476

Renal mass reduction results i ...... roteins in the remnant kidney.

@en

P2093

Hamid Moradi

http://www.w3.org/2001/XMLSchema#string

Hyun Ju Kim

http://www.w3.org/2001/XMLSchema#string

Jun Yuan

http://www.w3.org/2001/XMLSchema#string

Keith Norris

http://www.w3.org/2001/XMLSchema#string

Nosratola D Vaziri

http://www.w3.org/2001/XMLSchema#string

P2860

Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER

SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis

Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

Atherosclerosis

CD36: implications in cardiovascular disease

A simple method for the isolation and purification of total lipides from animal tissues

Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions

The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

P304

F1297-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.90761.2008

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

296

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19357177

http://www.w3.org/2001/XMLSchema#string

P932

2692452

http://www.w3.org/2001/XMLSchema#string